Evogene (EVGN) Reaches New 52-Week Low at $2.37

Share on StockTwits

Shares of Evogene Ltd (NASDAQ:EVGN) reached a new 52-week low on Thursday . The company traded as low as $2.37 and last traded at $2.39, with a volume of 2732 shares trading hands. The stock had previously closed at $2.40.

Separately, ValuEngine upgraded Evogene from a “hold” rating to a “buy” rating in a research note on Wednesday, November 7th.

An institutional investor recently raised its position in Evogene stock. Vanguard Group Inc. lifted its position in shares of Evogene Ltd (NASDAQ:EVGN) by 11.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 514,089 shares of the biotechnology company’s stock after purchasing an additional 50,823 shares during the period. Vanguard Group Inc. owned about 2.00% of Evogene worth $1,599,000 at the end of the most recent reporting period. Institutional investors own 35.29% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Evogene (EVGN) Reaches New 52-Week Low at $2.37” was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The legal version of this news story can be viewed at https://www.tickerreport.com/banking-finance/4001316/evogene-evgn-reaches-new-52-week-low-at-2-37.html.

Evogene Company Profile (NASDAQ:EVGN)

Evogene Ltd., a biotechnology company, focuses on the enhancement of crop productivity and performance in the United States, Germany, and internationally. It operates through three segments: Evogene, Evofuel, and Biomica. The Evogene segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance.

Featured Article: Conference Calls

Receive News & Ratings for Evogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evogene and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Community Trust Bancorp  Sets New 12-Month Low at $41.70
Community Trust Bancorp Sets New 12-Month Low at $41.70
Evogene  Reaches New 52-Week Low at $2.37
Evogene Reaches New 52-Week Low at $2.37
Comparing Siebert Financial  & Freedom
Comparing Siebert Financial & Freedom
Analyzing Harvard Bioscience  & Scientific Industries
Analyzing Harvard Bioscience & Scientific Industries
Contrasting Track Group  & Iridium Communications
Contrasting Track Group & Iridium Communications
Contrasting NANO DIMENSION/S  and Eltek
Contrasting NANO DIMENSION/S and Eltek


Leave a Reply

© 2006-2018 Ticker Report